NEW YORK--(BUSINESS WIRE)--March 21, 2005--Stem Cell Therapy International Corp. (SCTI), a leading supplier of xeno stem cells, that is, stem cells derived from animals, for transplant procedures in humans, today announced it has retained New York-based Stern & Co. to initiate an investor and media relations program. SCTI is the only company in the world that prepares stem cell transplants of animal fetal origin, of all 200 cell types, for human therapeutic use, and delivers the same worldwide.
